The drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be over, but many patients still have trouble getting the medicines.
The drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be over, but many patients still have trouble getting the medicines.Bill Coombs, who lives in Boston’s South End, has lost 28 pounds since he started using the obesity drug Wegovy.“I take it every Wednesday. So this Monday my prescription was up,” he says. “So I called to fill my prescription, and they said, ‘You're fine.’ When I went in ...
Novo Nordisk and Eli Lilly are the pharmaceutical companies that make the popular medications for diabetes and obesity. They recently said that their drugs are “available” again with the exception of the starting dose of Novo Nordisk’s Wegovy.David Knapp takes Lilly’s Mounjaro for his Type 2 diabetes and has a podcast, blog and YouTube channel called“They're doing the tricks, right? All the tricks,” he says. “They're going up a dose. They're moving back a dose.
The supply chain is complex for refrigerated medicines like Mounjaro and Zepbound, Eli Lilly spokesperson Rachel Sorvig wrote in an email to NPR. Novo Nordisk spokesperson Jamie Bennett told NPR the company can’t control which pharmacies or patients get Ozempic in the U.S. The company is limiting how much of the starting dose of Wegovy it produces to focus on supplying the drug to patients already on it and who work their way up to higher doses for continuing treatment.The drug companies are spending billions of dollars building new factories and expanding production.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Indonesia court fines drugmakers for toxic cough syrup that killed childrenThe court ordered the companies to pay 20 families who brought the suit compensation of 50 million rupiah ($3,217) for children who died and 60 million ($3,850) rupiah for children who were injured.
Read more »
Drugmakers at fault over toxic cough syrup, Indonesia court findsAn Indonesian court ordered two local companies to pay up to 60 million rupiah ($3,850) to each family whose children died of an acute kidney injury or were seriously injured after consuming toxic cough syrup.
Read more »
Mississippi sues drugmakers and pharmacy benefit managers over opioidsMississippi is suing drug manufacturers and pharmacy benefit managers alleging that opioids were over-prescribed. Attorney General Lynn Fitch filed suit Thursday in state court. The suit names 13 companies and says they participated in “the worst man-made epidemic in modern medical history.
Read more »
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiationsIt is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but is strongly opposed by drugmakers.
Read more »
White House says negotiated prices for Medicare drugs will save U.S. $6 billion, beneficiaries $1.5 billion in first yearIt is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but is strongly opposed by drugmakers.
Read more »
Biden administration releases prices of 10 drugs in Medicare negotiations, says U.S. will save $6 billion in first yearIt is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but is strongly opposed by drugmakers.
Read more »